{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:02:02Z","timestamp":1785333722453,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154239","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:28:16Z","timestamp":1783092496000},"page":"154239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and validation of HSP90AA1 as a risk gene in a HIF-1\u03b1 pathway-related prognostic signature for hepatocellular carcinoma"],"prefix":"10.1016","volume":"830","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0128-8128","authenticated-orcid":false,"given":"Yanyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hantao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrc.2026.154239_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10504","key":"10.1016\/j.bbrc.2026.154239_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The lancet commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","volume":"406","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bbrc.2026.154239_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154239_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2026.01.017","article-title":"Reversing the global burden of hepatocellular carcinoma","volume":"84","author":"Pinter","year":"2026","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154239_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154239_bib6","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.cgh.2023.01.039","article-title":"Breakthroughs in hepatocellular carcinoma therapies","volume":"21","author":"Singal","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154239_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","article-title":"Association between higher expression of Vav1 in hepatocellular carcinoma and unfavourable clinicopathological features and prognosis","volume":"31","author":"Ye","year":"2024","journal-title":"Protein Pept. Lett."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154239_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000488035","article-title":"Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition)","volume":"7","author":"Zhou","year":"2018","journal-title":"Liver Cancer"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154239_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cld.2020.07.001","article-title":"Role of biomarkers and biopsy in hepatocellular carcinoma","volume":"24","author":"Chen","year":"2020","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154239_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","article-title":"Analysis of the expression of PRDX6 in patients with hepatocellular carcinoma and its effect on the phenotype of hepatocellular carcinoma cells","volume":"25","author":"Mu","year":"2024","journal-title":"Curr. Genom."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154239_bib11","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154239_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.bbrc.2026.154239_bib13","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4254\/wjh.v16.i12.1371","article-title":"Targeting hypoxia and angiogenesis in hepatocellular carcinoma: new insights and therapeutic strategies","volume":"16","author":"Du","year":"2024","journal-title":"World J. Hepatol."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154239_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ph17081057","article-title":"Hypoxia as a target for combination with transarterial chemoembolization in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2026.154239_bib15","doi-asserted-by":"crossref","DOI":"10.2147\/JHC.S581550","article-title":"GRB2 promotes sorafenib resistance in hepatocellular carcinoma cells under hypoxia by activating the PI3K\/AKT signaling pathway","volume":"13","author":"He","year":"2026","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.bbrc.2026.154239_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218188","article-title":"Hypoxia-related CircARSB modulates lipid metabolism and innate immune crosstalk to influence immune checkpoint inhibitor response in hepatocellular carcinoma","volume":"639","author":"Song","year":"2026","journal-title":"Cancer Lett."},{"issue":"14","key":"10.1016\/j.bbrc.2026.154239_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411546","article-title":"Suppression of NASH-related HCC by farnesyltransferase inhibitor through inhibition of inflammation and hypoxia-inducible Factor-1alpha expression","volume":"24","author":"Yamada","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.bbrc.2026.154239_bib18","doi-asserted-by":"crossref","first-page":"18078","DOI":"10.1002\/cam4.6431","article-title":"UBE2S promotes malignant properties via VHL\/HIF-1alpha and VHL\/JAK2\/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma","volume":"12","author":"Wu","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2026.154239_bib19","article-title":"Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1 : miR-3130-5p enhances HCC growth via inhibiting FDX1","volume":"17","author":"Xu","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154239_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","article-title":"Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment","volume":"26","author":"Gudivada","year":"2025","journal-title":"Curr. Genom."},{"key":"10.1016\/j.bbrc.2026.154239_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5242437","article-title":"NCOA4: an immunomodulation-related prognostic biomarker in Colon adenocarcinoma and pan-cancer","volume":"2022","author":"Gu","year":"2022","journal-title":"J. Oncol."},{"issue":"R1","key":"10.1016\/j.bbrc.2026.154239_bib22","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154239_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2026.154239_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/lipd.70063","article-title":"Lipid\u2010soluble signaling molecular model predicts prognosis and immunotherapy response in gastric cancer","author":"Zhu","year":"2026","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154239_bib25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41467-021-21535-3","article-title":"The HIF-1alpha antisense long non-coding RNA drives a positive feedback loop of HIF-1alpha mediated transactivation and glycolysis","volume":"12","author":"Zheng","year":"2021","journal-title":"Nat. Commun."},{"issue":"51","key":"10.1016\/j.bbrc.2026.154239_bib26","doi-asserted-by":"crossref","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154239_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5483\/BMBRep.2022.55.9.177","article-title":"Melatonin inhibits glycolysis in hepatocellular carcinoma cells by downregulating mitochondrial respiration and mTORC1 activity","volume":"55","author":"Lee","year":"2022","journal-title":"BMB Rep."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154239_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-079X.2009.00742.x","article-title":"Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia","volume":"48","author":"Park","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bbrc.2026.154239_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1391636","article-title":"L-arginine combination with 5-fluorouracil inhibit hepatocellular carcinoma cells through suppressing iNOS\/NO\/AKT-mediated glycolysis","volume":"15","author":"Hu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154239_bib30","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1007\/s00210-025-04772-x","article-title":"Mitochondrial autophagy mechanism and berberine therapeutic target discovery in hepatocellular carcinoma based on single-cell and transcriptome analysis","volume":"399","author":"Wen","year":"2026","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154239_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgaf129","article-title":"Elucidating the molecular mechanism of bazhen decoction in the treatment of liver cancer: an integrated approach using network pharmacology, cancer databases, molecular docking, and experimental validation","volume":"78","author":"Wang","year":"2026","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154239_bib32","article-title":"Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validation","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154239_bib33","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1017\/erm.2026.10044","article-title":"Hypoxia and HIF signalling in tumour microenvironment: linking immune evasion, metabolic rewiring and epigenetic regulation","volume":"28","author":"Fawzul Ameer","year":"2026","journal-title":"Expert Rev. Mol. Med."},{"issue":"27","key":"10.1016\/j.bbrc.2026.154239_bib34","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.3748\/wjg.v27.i27.4453","article-title":"Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma","volume":"27","author":"Choi","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154239_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41419-022-05180-2","article-title":"MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"21","key":"10.1016\/j.bbrc.2026.154239_bib36","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41388-025-03335-x","article-title":"RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinoma","volume":"44","author":"Zhu","year":"2025","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbrc.2026.154239_bib37","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1002\/1878-0261.13080","article-title":"ERK signaling controls productive HIF-1 binding to chromatin and cancer cell adaptation to hypoxia through HIF-1alpha interaction with NPM1","volume":"15","author":"Koukoulas","year":"2021","journal-title":"Mol. Oncol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154239_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010151","article-title":"Hypoxia upregulates the expression of PD-L1 via NPM1 in breast cancer","volume":"13","author":"Yu","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154239_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12935-022-02479-0","article-title":"A role for the NPM1\/PTPN14\/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma","volume":"22","author":"Zhang","year":"2022","journal-title":"Cancer Cell Int."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:09:56Z","timestamp":1785330596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2601003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"alternative-id":["S0006291X2601003X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154239","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of HSP90AA1 as a risk gene in a HIF-1\u03b1 pathway-related prognostic signature for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154239"}}